| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |